Vidagliptin 100mg+ Depagliflozin 10mg +Metformin 1000mg SR Tablets

Coniglip-DP M 1000: Vildagliptin, Dapagliflozin, and Metformin (SR) Triple Combination

Welcome to the definitive product page for Coniglip-DP M 1000, a high-performance triple-action formula by Novalab Cardiac & Diabetic Care. Managing type 2 diabetes often requires a comprehensive approach, and this advanced combination of Vildagliptin 100mg, Dapagliflozin 10mg, and Metformin 1000mg SR is designed to provide robust, 24-hour glycemic control in one convenient tablet.

Advanced Composition: The Triple-Action Powerhouse

Coniglip-DP M 1000 brings together three of the most effective antidiabetic agents in modern medicine. Each component targets a different physiological pathway to ensure total blood sugar management.

• Vildagliptin (100mg Sustained Release): A potent DPP-4 inhibitor that works by increasing natural insulin secretion while reducing excess sugar production in the liver. The 100mg dose in a sustained-release format ensures steady enzyme inhibition throughout the day.

• Dapagliflozin (10mg): An innovative SGLT2 inhibitor that helps the kidneys remove excess sugar from the body through urine. It works independently of insulin, providing an additional layer of glucose control.

• Metformin Hydrochloride (1000mg Sustained Release): The foundation of diabetic therapy. Metformin improves insulin sensitivity and delays the absorption of sugar from the intestines. The 1000mg SR (Sustained Release) technology ensures a gradual release into the system for better digestive comfort and long-lasting efficacy.

Primary Uses of Coniglip-DP M 1000

This triple-drug combination is specifically formulated for adults who require advanced management for their blood sugar levels. Key uses include:

1. Management of Type 2 Diabetes Mellitus: Specifically for those whose blood sugar is not sufficiently controlled by a single or double-drug regimen.

2. Comprehensive Glycemic Control: Targets both fasting (morning) and post-prandial (after-meal) blood sugar levels.

3. HbA1c Reduction: Helps in significantly lowering glycated hemoglobin (HbA1c) levels over time, which is the primary marker for long-term diabetes management.

4. Cardiovascular Support: Emerging research suggests that components like Dapagliflozin offer extra protection for heart health in diabetic patients.

Exceptional Benefits for Patients

Choosing a triple-fixed-dose combination like Coniglip-DP M 1000 offers numerous advantages for long-term health and convenience.

1. Robust 24-Hour Coverage

Thanks to the Sustained Release (SR) technology in both Metformin and Vildagliptin, the medication remains active in your system for an extended period. This prevents sudden spikes in blood sugar and ensures consistent protection throughout the night.

2. Synergy for Better Results

Because these three drugs work through different mechanisms—kidney excretion, liver regulation, and pancreatic stimulation—they provide a “synergistic” effect. This often results in better sugar control than taking higher doses of just one medication.

3. Simplified Daily Routine

Instead of managing three separate prescriptions, Coniglip-DP M 1000 condenses your treatment into one tablet. This significantly reduces “pill burden,” making it much easier to stay consistent with your daily health routine.

4. Weight and Metabolic Support

Unlike some traditional diabetes medications that may cause weight gain, this combination—particularly the inclusion of Dapagliflozin—may support mild weight management by eliminating calories through glucose excretion.

5. Low Risk of Hypoglycemia

This modern combination is designed to work in a glucose-dependent manner, meaning it primarily acts when your blood sugar is high, which helps maintain a stable internal balance.

Why Choose Novalab Cardiac & Diabetic Care?

At Novalab, we focus on bringing precision-engineered pharmaceutical solutions to the market. Our Coniglip-DP M 1000 tablets are manufactured in state-of-the-art facilities, ensuring that every tablet meets the highest standards of purity and efficacy.

• Premium Quality: Rigorous testing for consistent drug release.

• Scientific Innovation: Using the latest SR (Sustained Release) technology for patient comfort.

• Commitment to Care: Dedicated to helping patients achieve their wellness goals through reliable cardiac and diabetic products.

How It Works: The Science Simplified

The brilliance of Coniglip-DP M 1000 lies in its multi-pathway strategy:

• The Liver: Metformin and Vildagliptin tell the liver to stop producing unnecessary sugar.
• The Pancreas: Vildagliptin helps the pancreas release insulin more efficiently after you eat.
• The Kidneys: Dapagliflozin acts as a filter, allowing the kidneys to flush out excess sugar through your urine.

For more information or to inquire about bulk supply, visit our official website at www.novalabcardiac.com.